VAV1 and acute lymphoblastic leukemia: Given the implication of Vav1 in T cell development and signaling [16], we next tested the biological activity of the mutant proteins using luciferase reporter-based c-Jun N-terminal kinase (JNK) and NFAT activity assays in the T cell acute lymphoblastic leukemia Jurkat cell line.